Latest News:
Subscribe to the latest in micro-cap news and podcasts, straight to your inbox.
Subscribe Now
Facebook Twitter Instagram Youtube Linkedin Apple Spotify

Featured News

NexTech AR
NexTech AR Reports $6 million in Revenues for its Audited Period- Ended December 31st 2019. Major Growth in AR Trends Seen Accelerating in 2020! (NEXCF)
Read Full Article
About Hemp-Derived CBD
Cannabidiol (CBD) is one of at least 113 active cannabinoids identified in cannabis. It is a major phytocannabinoid, accounting for up to 40% of the plant’s extract.
Read More
Remedi – CBD Professionals you Can Trust
The team of Remedi is a collaboration project of hemp and CBD professionals.
Read More
Pressure BioSciences' New CBD Technology
Pressure Biosciences unveils new CBD beverage infusing technology
Watch Video

Hot Stocks of the Day

 
Hot Stocks of the Day by TradingView

Latest News

HempAmericana, Inc. Discusses Their New eCommerce Platform with The Stock Day Podcast (HMPQ) April, 2020
Radio Interviews 

HempAmericana, Inc. Discusses Their New eCommerce Platform with The Stock Day Podcast (HMPQ) April, 2020

Stock Day Media Comments Off on HempAmericana, Inc. Discusses Their New eCommerce Platform with The Stock Day Podcast (HMPQ) April, 2020

Phoenix, Arizona–(Newsfile Corp. – April 6, 2020) – The Stock Day Podcast welcomed HempAmericana, Inc. (OTC Pink: HMPQ), an emerging

Can B Corp Announces Fourth Quarter and Full Year 2019 Results
Cannabis 

Can B Corp Announces Fourth Quarter and Full Year 2019 Results

Stock Day Media Comments Off on Can B Corp Announces Fourth Quarter and Full Year 2019 Results
Mateon Achieves Milestone in its Development of OT-101, a Phase 3 Clinical Drug Candidate, Against COVID-19
BioTech 

Mateon Achieves Milestone in its Development of OT-101, a Phase 3 Clinical Drug Candidate, Against COVID-19

Stock Day Media Comments Off on Mateon Achieves Milestone in its Development of OT-101, a Phase 3 Clinical Drug Candidate, Against COVID-19
Premier Biomedical Realigns Business to Eliminate Convertible Debt, Cancel Reverse Split & Fund Covid-19 R&D
BioTech 

Premier Biomedical Realigns Business to Eliminate Convertible Debt, Cancel Reverse Split & Fund Covid-19 R&D

Stock Day Media Comments Off on Premier Biomedical Realigns Business to Eliminate Convertible Debt, Cancel Reverse Split & Fund Covid-19 R&D

Cannabis

Can B Corp Announces Fourth Quarter and Full Year 2019 Results
Cannabis 

Can B Corp Announces Fourth Quarter and Full Year 2019 Results

Stock Day Media Comments Off on Can B Corp Announces Fourth Quarter and Full Year 2019 Results

Annual Revenue Increased 345% Improved Gross Margin of 74% HICKSVILLE, NY, April 06, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE –

GB Sciences Completes and Achieves Statistical Significance in Preclinical Study of Its Proprietary Parkinson’s Disease Cannabinoid Formulations
Cannabis 

GB Sciences Completes and Achieves Statistical Significance in Preclinical Study of Its Proprietary Parkinson’s Disease Cannabinoid Formulations

Stock Day Media Comments Off on GB Sciences Completes and Achieves Statistical Significance in Preclinical Study of Its Proprietary Parkinson’s Disease Cannabinoid Formulations
CBD Unlimited Provides Quarterly Update and Reports Record Revenues
Cannabis 

CBD Unlimited Provides Quarterly Update and Reports Record Revenues

Stock Day Media Comments Off on CBD Unlimited Provides Quarterly Update and Reports Record Revenues
HempAmericana Announces Launch of New and Improved Ecommerce Sales Platform
Cannabis 

HempAmericana Announces Launch of New and Improved Ecommerce Sales Platform

Stock Day Media Comments Off on HempAmericana Announces Launch of New and Improved Ecommerce Sales Platform

Energy

American Battery Metals Corporation Hires Principal Chemical Engineer, Formerly at Tesla
Energy 

American Battery Metals Corporation Hires Principal Chemical Engineer, Formerly at Tesla

Stock Day Media Comments Off on American Battery Metals Corporation Hires Principal Chemical Engineer, Formerly at Tesla

INCLINE VILLAGE, NV / ACCESSWIRE / April 2, 2020 / American Battery Metals Corporation (OTCQB:ABML) (the “Company”), an American-owned advanced

First Cobalt Produces Battery Grade Cobalt Sulfate
Energy 

First Cobalt Produces Battery Grade Cobalt Sulfate

Stock Day Media Comments Off on First Cobalt Produces Battery Grade Cobalt Sulfate
H/Cell Energy Obtains Contract to Equip Coronavirus Tents
Energy 

H/Cell Energy Obtains Contract to Equip Coronavirus Tents

Stock Day Media Comments Off on H/Cell Energy Obtains Contract to Equip Coronavirus Tents
Amazing Energy Oil and Gas, Co Joins us on the Stock Day Podcast (AMAZ) February, 2020
Energy News Radio Interviews 

Amazing Energy Oil and Gas, Co Joins us on the Stock Day Podcast (AMAZ) February, 2020

Stock Day Media Comments Off on Amazing Energy Oil and Gas, Co Joins us on the Stock Day Podcast (AMAZ) February, 2020

Mining

Marathon Gold Announces Positive Pre-Feasibility Study for the Valentine Gold Project
Mining 

Marathon Gold Announces Positive Pre-Feasibility Study for the Valentine Gold Project

Stock Day Media Comments Off on Marathon Gold Announces Positive Pre-Feasibility Study for the Valentine Gold Project

TORONTO, April 06, 2020 (GLOBE NEWSWIRE) — Marathon Gold Corporation (“Marathon” or the “Company”) (TSX: MOZ) is pleased to report the results

Aben Announces COVID-19 Response
Mining 

Aben Announces COVID-19 Response

Stock Day Media Comments Off on Aben Announces COVID-19 Response
RNC Announces Strong Fourth Quarter Results Including Gold Production of 26,874 oz, Adjusted Earnings(2) of $14 million, 2H19 AISC(1),(2) Guidance Beat and No Change to 2020 guidance
Mining 

RNC Announces Strong Fourth Quarter Results Including Gold Production of 26,874 oz, Adjusted Earnings(2) of $14 million, 2H19 AISC(1),(2) Guidance Beat and No Change to 2020 guidance

Stock Day Media Comments Off on RNC Announces Strong Fourth Quarter Results Including Gold Production of 26,874 oz, Adjusted Earnings(2) of $14 million, 2H19 AISC(1),(2) Guidance Beat and No Change to 2020 guidance
Drilling at Las Conchitas Extends Near Surface, High-Grade Gold Mineralization Across Multiple Intercepts at the Bayacun Zone, Highlighted by 84.64 g/t Gold Over 1.6 Meters
Mining 

Drilling at Las Conchitas Extends Near Surface, High-Grade Gold Mineralization Across Multiple Intercepts at the Bayacun Zone, Highlighted by 84.64 g/t Gold Over 1.6 Meters

Stock Day Media Comments Off on Drilling at Las Conchitas Extends Near Surface, High-Grade Gold Mineralization Across Multiple Intercepts at the Bayacun Zone, Highlighted by 84.64 g/t Gold Over 1.6 Meters

Biotech

Mateon Achieves Milestone in its Development of OT-101, a Phase 3 Clinical Drug Candidate, Against COVID-19
BioTech 

Mateon Achieves Milestone in its Development of OT-101, a Phase 3 Clinical Drug Candidate, Against COVID-19

Stock Day Media Comments Off on Mateon Achieves Milestone in its Development of OT-101, a Phase 3 Clinical Drug Candidate, Against COVID-19

OT-101 – a TGF-β2 antisense – has demonstrated potent antiviral activity against COVID-19   OT-101 is part of the Company’s proprietary

Premier Biomedical Realigns Business to Eliminate Convertible Debt, Cancel Reverse Split & Fund Covid-19 R&D
BioTech 

Premier Biomedical Realigns Business to Eliminate Convertible Debt, Cancel Reverse Split & Fund Covid-19 R&D

Stock Day Media Comments Off on Premier Biomedical Realigns Business to Eliminate Convertible Debt, Cancel Reverse Split & Fund Covid-19 R&D
First Two Patients Enrolled in Randomized Phase 2, COVID-19 Trial with Leronlimab; Five More Severely Ill COVID-19 Patients Treated Under Emergency IND and Two Patients Have Already Extubated
BioTech News 

First Two Patients Enrolled in Randomized Phase 2, COVID-19 Trial with Leronlimab; Five More Severely Ill COVID-19 Patients Treated Under Emergency IND and Two Patients Have Already Extubated

Stock Day Media Comments Off on First Two Patients Enrolled in Randomized Phase 2, COVID-19 Trial with Leronlimab; Five More Severely Ill COVID-19 Patients Treated Under Emergency IND and Two Patients Have Already Extubated
Treatment with CytoDyn’s Leronlimab Indicates Trend Toward Immunological Restoration in Severely Ill COVID-19 Patients (CYDY)
BioTech 

Treatment with CytoDyn’s Leronlimab Indicates Trend Toward Immunological Restoration in Severely Ill COVID-19 Patients (CYDY)

Stock Day Media Comments Off on Treatment with CytoDyn’s Leronlimab Indicates Trend Toward Immunological Restoration in Severely Ill COVID-19 Patients (CYDY)